Oleandomycin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | New Products |
| Catalog number | BBF-02617 |
| CAS | 3922-90-5 |
| Molecular Weight | 687.86 |
| Molecular Formula | C35H61NO12 |
| Purity | >95% by HPLC |
Online Inquiry
Description
Oleandomycin is a 16-membered macrocyclic lactone originally isolated from Str. antibioticus. It has broad spectrum antibacterial activity.
Specification
| Synonyms | Matromycin; Amimycin; Landomycin; Antibiotic PA-105 |
| Storage | Store at -20°C |
| IUPAC Name | (3R,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione |
| Canonical SMILES | CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)O)OC)C)C)C)O)C)C)O)N(C)C |
| InChI | InChI=1S/C35H61NO12/c1-16-14-35(15-43-35)32(40)19(4)27(37)18(3)22(7)46-33(41)21(6)31(47-26-13-25(42-11)28(38)23(8)45-26)20(5)30(16)48-34-29(39)24(36(9)10)12-17(2)44-34/h16-31,34,37-39H,12-15H2,1-11H3/t16-,17+,18-,19+,20+,21+,22+,23-,24-,25-,26-,27-,28-,29+,30-,31-,34-,35+/m0/s1 |
| InChI Key | RZPAKFUAFGMUPI-QESOVKLGSA-N |
| Source | Streptomyces sp. |
Properties
| Appearance | Colorless Columnar Crystals |
| Application | anti-bacterial agents |
| Antibiotic Activity Spectrum | Gram-positive bacteria; Gram-negative bacteria; mycobacteria |
| Boiling Point | 802.6°C at 760 mmHg |
| Melting Point | 110°C |
| Density | 1.21 g/cm3 |
| Solubility | Soluble in ethanol, methanol, DMF or DMSO. Limited water solubility. |
Reference Reading
1. Identification and antibacterial activity of a new oleandomycin derivative from Streptomyces antibioticus
Bo Yeon Kim, Jeong Ah Park, Beom Seok Kim, Sang Kil Lee, Sun Young Kim, Yeo Joon Yoon, Jong Seog Ahn, Hyuncheol Oh J Antibiot (Tokyo) . 2005 Mar;58(3):196-201. doi: 10.1038/ja.2005.23.
During the study on the oleandomycin production, we purified a new oleandomycin derivative having a macrolactone of which biosynthesis does not follow the genetic architecture of the oleandomycin PKS. The molecular formula for the compound was suggested as C35H59NO11 on the basis of the analysis of NMR and HRMS data (m/z 670.4185, Delta-1.9mmu, calcd for C35H60NO11). 13C NMR assignments and analysis of COSY, HMBC and HMQC data suggested that the compound differs from oleandomycin by formation of the olefinic functionality resulting from the dehydration of a hydroxy group in oleandomycin. The new oleandomycin derivative has antibacterial activities similar to those of oleandomycin agaisnt Enterococcus faecalis, Bacillus subtilis and Staphylococcus aureus.
2. Resistance to oleandomycin in Streptomyces antibioticus, the producer organism
J A Salas, J F Fierro, C Hardisson J Gen Microbiol . 1987 Jul;133(7):1931-9. doi: 10.1099/00221287-133-7-1931.
Resistance to oleandomycin in Streptomyces antibioticus, the producer organism, was studied. The organism was highly resistant in vivo to the antibiotic but sensitive to other macrolides and lincosamides. Protein synthesis in vivo by mycelium of S. antibioticus was more resistant to oleandomycin than that by mycelium of Streptomyces albus G, an oleandomycin-sensitive strain, and this resistance was dependent on the age of the culture, older mycelium of S. antibioticus being more resistant to oleandomycin than young mycelium. [3H]Oleandomycin was capable of binding to the same extent to the 50S subunits of the ribosomes of both organisms. Oleandomycin also inhibited in vitro protein synthesis by ribosomes obtained from an oleandomycin-production medium at the time when maximum levels of oleandomycin were being produced. A clear difference between the ability of the two organisms to incorporate exogenous oleandomycin was observed. Thus, while S. albus G took up oleandomycin, S. antibioticus showed a decreased permeability to the antibiotic, suggesting a role for cell permeability in self-resistance.
3. Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives
F C Sciavolino, J A Retsema, A R English, A A Nagel, G M Bright Antimicrob Agents Chemother . 1984 Jan;25(1):113-7. doi: 10.1128/AAC.25.1.113.
Chemical modification of the macrolide antibiotic oleandomycin (C-1) is described. Reductive amination of 11-acetyl-4"-deoxy-4"-oxo-oleandomycin (C-6) with ammonium acetate provides amino-oleandomycin derivative C-7 in which the 4"-amine is oriented in the axial configuration. The structure-activity relationship of a series of 4"-sulfonamide analogs prepared from amino-oleandomycin derivative C-7 is discussed. Noteworthy is the significant in vitro potency enhancement of the para-chlorobenzenesulfonamide analog C-12 over that of the parent oleandomycin. The absolute configuration of the 4"-amino-oleandomycin derivative C-7 was established through X-ray analysis of the para-iodobenzenesulfonamide analog C-14.
Recommended Products
| BBF-04659 | Spinosyn J | Inquiry |
| BBF-03796 | Bambermycin | Inquiry |
| BBF-03819 | Spinosyn A | Inquiry |
| BBF-03761 | Tunicamycin | Inquiry |
| BBF-05730 | Abamectin | Inquiry |
| BBF-03802 | Doramectin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
